Regulatory medicine and vascular medicine are very similar. Regulatory medicine is more alternative medicine. The classic regulatory medicine is acupuncture. It re-regulates the body. It’s not based on anatomy and biochemistry; it’s based on physiological regulation of systems. Electro acupuncture, some of the machines we use in our office, like the Moore machine, these are all re-regulating machines. They re-regulate the body, the physiology. We combine all of these.
Our treatment is we attack the underlying vascular cause of what’s happening – the circulation cause. In circulation disease, that has now segregated itself. It’s kind of self-segregated itself, if you watch the medical literature over the years. The large vascular disease today, called macro vascular includes the large vessels in the neck, the aorta, the abdomen, the legs, and on the surface of the heart. These are the arteries that they operate on, put stents in, put grafts in, and replace – whatever they are doing today versus the microcirculation.
Microcirculation involves new thinking. It concerns the small vessels. You could arguably use the term, “capillaries”, because all capillaries are microvessels, but not all microvessels are capillaries. So they’re not quite synonymous. For the average person, capillaries are good enough. What we found going back to these heart studies was, when I realized the way chelation is working, it’s doing something in the microcirculation. If you go back to macro-circulatory disease, it has always bothered me that you could take a patient who’s had a stroke, for instance, and look at these arteries in the neck. One artery could be 100% blocked and another artery could be completely open.
You look at all these theories – smoking, cholesterol, blood pressure. How does it work if one artery is blocked and another artery is clean, since just as much cholesterol, high blood pressure – whatever you are looking at – is going down both arteries?
When somebody says, “How does that work?” doctors are taught to say, to parrot, “Well, atherosclerosis behaves as a skip lesion, which means it hits one artery and skips another. This is sheer rampant sophistry. Why don’t you just say that you don’t know? Because then you can learn something. When you just make stuff up – “Oh, it’s a skip lesion, so we are not going to look at it anymore” – nobody looks at it anymore. That always bothered me, especially doing cardiovascular medicine. It never made sense.
The system is focusing on macro vascular disease. Interestingly, in the last 10 or so years, there is a realization that microvascular disease may be driving a lot of these problems. The debate going on in the literature today is how do we measure this? They know it’s wrong, but they can’t see it. You can have what Braverman calls in her book “microvascular angina,” sometimes called, “Syndrome X”. No standard cardiac test that they do today will pick that up. They can’t pick that up. If a cardiologist is smart, and he is doing an echocardiogram, and he sees what’s referred to in their language today as “abnormal diastolic dysfunction” – lusitrophic dysfunction – that is synonymous with microvascular disease in the heart muscle itself. They just do the same things that they do for macro vascular disease – the same drugs. What they do is just very narrow thinking. What we’re concentrating on in our office is microvascular disease.